Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Among patients prescribed semaglutide, 62% of patients with class 3 obesity maintained or continued to lose weight after one year, compared to 37% of patients with a healthy BMI
Support infrastructure - Unlimited phone/SMS support, included anti-nausea medication, and automatic refills (if desired) create a structured support system that may help with adherence
Gastric bypass surgery, UCLA Health Gastric bypass surgery, MedlinePlus (2022) Gastric bypass versus gastric sleeve surgery, University of Pittsburgh Medical Center The potential of semaglutide once-weekly in patients without Type 2 diabetes with weight regain or insufficient weight loss after bariatric surgerya retrospective analysis, Obesity Surgery (2022) Gastric sleeve surgery, Cleveland Clinic (2022) Gastric sleeve surgery: Qualifications, complications, and more, University of Pittsburgh Medical Center Weight regain following sleeve gastrectomy a systematic review, Obesity Surgery (2016) Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence, Obesity (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Who Sees the Greatest Lipid Benefit Not every patient responds identically
